ASP 3026

Based on 20 reference(s) in Google Scholar 80 100 20

Axon 2005

CAS [1097917-15-1]

MF C29H40N8O3S
MW 580.74

  • Purity: 99%
  • Soluble in 0.1N HCl(aq) and DMSO

ASP 3026

Description

Selective inhibitor of the oncogenic fusion kinase EML4-ALK; ASP3026 has a broad safety margin and inhibitory activity at the gatekeeper mutation; potential agent in EML4-ALK fusion positive NSCLC patients, that have relapsed to Crizotinib (Axon 1660)

Order
Size Unit Price Stock
2 mg €80.00 In Stock
5 mg €110.00 In Stock
25 mg €330.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €160.00 In Stock
2 x 25 mg €500.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...